William Blair analyst Matt Larew has maintained their neutral stance on ATR stock, giving a Hold rating on November 30.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Matt Larew’s rating is based on AptarGroup’s recent acquisition of Sommaplast, a Brazilian company specializing in pharma packaging solutions. This acquisition, while relatively small in terms of immediate financial impact, aligns well with AptarGroup’s strategy to expand its presence in the pharmaceutical sector, particularly in Latin America. The company has a long-standing manufacturing presence in Brazil, and this acquisition is expected to enhance its capabilities and market reach in the region.
Despite the strategic fit and potential synergies from the acquisition, the financial contribution from Sommaplast is expected to be minimal in the short term. Additionally, AptarGroup’s shares are currently trading at a multiple of 20.7 times the estimated earnings per share for 2026, which suggests that the stock is fairly valued at present. As a result, Matt Larew has assigned a Hold rating, indicating that investors may want to maintain their current positions rather than buying more or selling off their shares.
In another report released on November 30, TR | OpenAI – 4o also reiterated a Hold rating on the stock with a $131.00 price target.
Based on the recent corporate insider activity of 72 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ATR in relation to earlier this year.